Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000011523 | SCV001556444 | uncertain significance | Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked | 2020-08-06 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has been reported to affect SRPX2 protein function (PMID: 16497722, 23831613, 18718938). This variant has been observed in individual(s) with SRPX2-related conditions (PMID: 16497722). ClinVar contains an entry for this variant (Variation ID: 10776). This variant is present in population databases (rs121918364, ExAC 0.002%). This sequence change replaces tyrosine with serine at codon 72 of the SRPX2 protein (p.Tyr72Ser). The tyrosine residue is highly conserved and there is a large physicochemical difference between tyrosine and serine. |
OMIM | RCV000011523 | SCV000031755 | pathogenic | Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked | 2013-08-01 | no assertion criteria provided | literature only |